Sotera Health Company $SHC Shares Sold by Versor Investments LP

Versor Investments LP trimmed its stake in shares of Sotera Health Company (NASDAQ:SHC) by 69.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,000 shares of the company’s stock after selling 31,300 shares during the period. Versor Investments LP’s holdings in Sotera Health were worth $220,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of SHC. Sculptor Capital LP raised its position in shares of Sotera Health by 27.2% during the 2nd quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock worth $127,880,000 after purchasing an additional 2,462,489 shares during the last quarter. MIG Capital LLC increased its stake in Sotera Health by 3.3% during the 2nd quarter. MIG Capital LLC now owns 5,282,339 shares of the company’s stock worth $58,740,000 after buying an additional 168,388 shares in the last quarter. Two Seas Capital LP lifted its position in shares of Sotera Health by 21.1% in the second quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock valued at $44,712,000 after acquiring an additional 699,731 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Sotera Health by 1.9% in the second quarter. Geode Capital Management LLC now owns 2,913,391 shares of the company’s stock valued at $32,402,000 after acquiring an additional 53,654 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in shares of Sotera Health by 40.2% in the second quarter. Bank of America Corp DE now owns 916,156 shares of the company’s stock worth $10,188,000 after acquiring an additional 262,772 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of SHC stock opened at $17.12 on Friday. The company has a debt-to-equity ratio of 4.04, a current ratio of 2.38 and a quick ratio of 2.18. The company has a market capitalization of $4.86 billion, a PE ratio of 90.11 and a beta of 1.82. The firm’s 50-day moving average is $17.92 and its two-hundred day moving average is $16.52. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $19.85.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on SHC shares. Wells Fargo & Company lowered Sotera Health to an “overweight” rating in a report on Thursday, January 8th. JPMorgan Chase & Co. raised their price target on shares of Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. William Blair began coverage on shares of Sotera Health in a research note on Thursday, December 18th. They issued an “outperform” rating on the stock. Finally, BMO Capital Markets began coverage on Sotera Health in a report on Thursday, November 13th. They set an “outperform” rating and a $19.00 target price on the stock. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $20.00.

Insider Activity at Sotera Health

In related news, Director Pincus & Co. Warburg sold 9,720,000 shares of the stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total value of $158,727,600.00. Following the completion of the transaction, the director directly owned 34,102,952 shares in the company, valued at approximately $556,901,206.16. This represents a 22.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Michael B. Jr. Petras sold 434,104 shares of Sotera Health stock in a transaction on Monday, December 8th. The shares were sold at an average price of $16.45, for a total value of $7,141,010.80. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 17,384,104 shares of company stock worth $284,024,511. Insiders own 47.55% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.